This cost-effectiveness analysis of care options for group A streptococcus patients is the first to include community pharmacy as a possible point of care.
Michael E. Klepser, PharmD
Advertisement
Articles by Michael E. Klepser, PharmD
Advertisement
This cost-effectiveness analysis of care options for group A streptococcus patients is the first to include community pharmacy as a possible point of care.